fig1

Immune checkpoint inhibitors in hepatocellular carcinoma therapy: resistance mechanisms, liver transplantation challenges and management strategies

Figure 1. Schematic diagram of the TME associated with the recurrence of HCC after LT (created with BioGDP.com). TME: Tumor microenvironment; HCC: hepatocellular carcinoma; LT: liver transplantation.

Cancer Drug Resistance
ISSN 2578-532X (Online)

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/